Joel Abreu

Prof. Joel Abreu

Departament of Pharmacy, University of Brasília, Brasília, Distrito Federal, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2019 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
GPGuilherme Souza Prado
Guilherme Souza Prado
PBPingdwende Kader Aziz Bamogo
Pingdwende Kader Aziz Bamogo
Joel AbreuJoel Abreu
Joel Abreu
FGFrançois-Xavier Gillet
François-Xavier Gillet
VSVanessa Olinto dos Santos
Vanessa Olinto dos Santos
SLSéverine Lacombe
Séverine Lacombe
Insect resistance in crops represents a main challenge for agriculture. Transgenic approaches based on proteins displaying insect resistance properties are widely used as efficient breeding strategies. To extend the spectrum of targeted pathogens and overtake the development of resistance, molecular evolution strategies have been used on genes encoding these proteins to generate thousands of variants with new or improved functions. The cotton boll weevil (Anthonomus grandis) is one of the major pests of cotton in the Americas. An α-amylase inhibitor (α-AIC3) variant previously developed via molecular evolution strategy showed inhibitory activity against A. grandis α-amylase (AGA). We produced in a few days considerable amounts of α-AIC3 using an optimised transient heterologous expression system in Nicotiana benthamiana. This high α-AIC3 accumulation allowed its structural and functional characterizations. We demonstrated via MALDI-TOF MS/MS technique that the protein was processed as expected. It could inhibit up to 100% of AGA biological activity whereas it did not act on α-amylase of two non-pathogenic insects. These data confirmed that N. benthamiana is a suitable and simple system for high-level production of biologically active α-AIC3. Based on other benefits such as economic, health and environmental that need to be considerate, our data suggested that α-AIC3 could be a very promising candidate for the production of transgenic crops resistant to cotton boll weevil without lethal effect on at least two non-pathogenic insects. We propose this expression system can be complementary to molecular evolution strategies to identify the most promising variants before starting long-lasting stable transgenic programs.

Verified
Journal Article
Open access
PDF file
KAKellen Cruvinel Rodrigues Andrade
Kellen Cruvinel Rodrigues Andrade
Mauricio Homem-de-MelloMauricio Homem-de-Mello
Mauricio Homem-de-Mello
JMJulia Almeida Motta
Julia Almeida Motta
MBMarina Borges
Marina Borges
Joel AbreuJoel Abreu
Joel Abreu
Perola Oliveira MagalhaesPerola Oliveira Magalhaes
Perola Oliveira Magalhaes
L-asparaginase is an essential drug used to treat acute lymphoid leukemia (ALL), a cancer of high prevalence in children. Several adverse reactions associated with L-asparaginase have been observed, mainly caused by immunogenicity and allergenicity. Some strategies have been adopted, such as searching for new microorganisms that produce the enzyme and applying protein engineering. Therefore, this work aimed to elucidate the molecular structure and predict the immunogenic profile of L-asparaginase from Penicillium cerradense, recently revealed as a new fungus of the genus Penicillium and producer of the enzyme, as a motivation to search for alternatives to bacterial L-asparaginase. In the evolutionary relationship, L-asparaginase from P. cerradense closely matches Aspergillus species. Using in silico tools, we characterized the enzyme as a protein fragment of 378 amino acids (39 kDa), including a signal peptide containing 17 amino acids, and the isoelectric point at 5.13. The oligomeric state was predicted to be a homotetramer. Also, this L-asparaginase presented a similar immunogenicity response (T- and B-cell epitopes) compared to Escherichia coli and Dickeya chrysanthemi enzymes. These results suggest a potentially useful L-asparaginase, with insights that can drive strategies to improve enzyme production.

26 October 2023 in Future Microbiology
Verified
Journal Article
Closed access
KAKellen Cruvinel Rodrigues Andrade
Kellen Cruvinel Rodrigues Andrade
Joel AbreuJoel Abreu
Joel Abreu
MBMarina Borges
Marina Borges
LALetícia Santos Abrunhosa
Letícia Santos Abrunhosa
ARAna Luisa Leôncio Rodrigues
Ana Luisa Leôncio Rodrigues
Perola Oliveira MagalhaesPerola Oliveira Magalhaes
Perola Oliveira Magalhaes
Aim: To review the available literature about heterologous expression of fungal L-asparaginase (L-ASNase). Materials & methods: A search was conducted across PubMed, Science Direct, Scopus and Web ... Plain language summary Asparaginase is a common treatment for the most common type of leukemia in children. These treatments generally use asparaginase sourced from bacteria. Some people can experi...

20 January 2019 in Australian Journal of Crop Science
Verified
Journal Article
Closed access
ECElisiane Inês Dall'óglio Chaves
Elisiane Inês Dall'óglio Chaves
FPFederal University of Paraná (UFPR) – Campus Palotina – PR
Federal University of Paraná (UFPR) – Campus Palotina – PR
VGVandeir Francisco Guimarães
Vandeir Francisco Guimarães
EVEliane Cristina Gruszka Vendruscolo
Eliane Cristina Gruszka Vendruscolo
MSMarise Fonseca dos Santos
Marise Fonseca dos Santos
EVEdmar Soares de Vasconcelos
Edmar Soares de Vasconcelos

6 February 2022 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
ERElias El-Shaddai dos Santos Nery Nunes Ribeiro
Elias El-Shaddai dos Santos Nery Nunes Ribeiro
Joel AbreuJoel Abreu
Joel Abreu
FBFabiana Brandao
Fabiana Brandao
Justification: There is a solid worldwide call to control the use of antimicrobials associated with new therapeutic approaches against multidrug-resistant infections, such as those caused by the species E. faecalis and E. faecium, commensal opportunistic pathogens usually present in healthcare-related infections (HAI). The high adaptability of these pathogens to the nosocomial environment and the acquisition of resistance and virulence genes are among the main factors contributing to the worsening of these infections. CRISPR-Cas acts as a bacterial defense system, evolutionarily selected due to the association of bacteria with viruses, present in some strains of E. faecalis and E. faecium. It is speculated that CRISPR-Cas could be used in different vectors, including conjugative plasmids, for editing and inactivating resistance genes. Goals: To investigate the use of CRISPR-Cas in conjugative plasmids to control the spread of multidrug-resistant enterococcal strains. Methodology: This is a scope-based review, applying selection criteria and inclusion of studies in the time interval between 2016 and 2021. Conclusion: Molecular editing tools, such as CRISPR-Cas, may be promising alternatives in controlling multidrug-resistant infections and contribute to the control of hospital spread. Strains that do not have this system are more susceptible to acquiring mobile genetic elements, acquiring resistance and virulence genes. The applicability of CRISPR-Cas in conjugative plasmids is an innovative and feasible method, capable of interfering in the mobile genetic elements acquisition, and consequently, reducing resistance and virulence expression, both in the Enterococcus genus and in others.

12 March 2022 in Research, Society and Development
Verified
Open access
PDF file
Joel AbreuJoel Abreu
Joel Abreu
FBFabiana Brandao
Fabiana Brandao
How extensively frenzy could a viral infection cause? The virus of the betacoronavirus family, SARS-CoV-2, agent of COVID-19, has shaken economic and health structures around the world since the end of 2019. There are several attempts to prevent the spread of this virus, from effective sanitary measures, or the "gold rush" for drug repositioning, to the accelerated development of vaccines. In this sense, the empirical use of antibiotics has increased even more in hospitalized patients to avoid bacterial coinfections, which could be an aggravating factor in unfavorable clinical outcomes. However, the non-rational use of these drugs, in addition to contributing to the emergence of multidrug-resistant microorganisms, can contribute to a worrying situation, intestinal dysbiosis, an event with "pleiotropic" proportions, which can significantly worsen SARS- CoV-2. Different studies report that hospitalized patients with COVID-19 have shown a reduction in the population of probiotic butyrate-producing bacteria, such as Faecalibacterium prausnitzii, in addition to a reduction in the Firmicute/Bacteroidetes ratio and an increase in the proportion of Actinobacteria, among other opportunistic pathogens. This imbalance in the gut microbiota has been correlated with increased pro-inflammatory biochemical indicators and reduced anti-inflammatory drugs, which contribute to unfavorable outcomes. Thus, understanding the harmonic and disharmonious microbial interactions in the context of COVID-19 can help develop non-pharmacological strategies capable of modulating the host response and avoiding complications, particularly concerning patients with comorbidities.